Boston Scientific rose over 4.4%, Q3 performance exceeded expectations + raised full-year adjusted earnings guidance

智通財經
2025.10.22 14:50
醫療器械公司波士頓科學漲超 4.4%，報 104.36 美元。消息面上，波士頓科學第三季度銷售額同比增長 20% 至 50.7 億美元，超出華爾街分析師預期的 49.7 億美元。其中，心血管部門的銷售額同比增長 22% 至 33.4 億美元，高於預期的 32.7 億美元。期內調整後每股收益為 75 美分，高於預期的 71 美分。公司上調全年調整後每股收益指引至 3.02 至 3.04 美元，超過分析師預期的 2.98 美元。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.